non-Hispanic white (n = 55) | Black (n = 205) | Other (n = 6) | p-value | |
---|---|---|---|---|
Female % (n) | 80 (44) | 75.6 (155) | 83.3 (5) | NS |
Age at initial evaluation (years) | 6.67 +/− 1.83 | 6.30+/− 2.02 | 7.94 +/− 1.00 | NS |
Age at initial symptoms/ signs (years) | 5.42 +/− 1.89 | 4.44 +/− 2.01 | 6.48 +/− 2.15 | 0.004* |
Weight z-score | 1.32 +/− 1.07 | 1.25 +/− 1.39 | 0.84+/− 1.56 | NS |
BMI z-score | 1.28 +/− 0.92 | 1.24 +/−1.29 | 1.33 +/− 0.83 | NS |
Systolic BP | 106 +/− 7.44 | 103+/− 7.85 | 101.29 +/− 8.83 | 0.008* |
Diastolic BP | 65.5 +/− 6.47 | 64.4 +/−6.77 | 67.0+/− 6.03 | NS |
Hypertension % (n) | 16.4 (9) | 11.2 (23) | 16.7 (1) | NS |
Tanner stage (pubic hair) | 2.09 +/− 0.53 | 2.33 +/− 0.59 | 1.83 +/− 0.41 | 0.006* |
Testosterone (ng/dL) | 11.2 +/− 17.0 | 6.78 +/− 5.32 | 6.97 +/− 1.50 | NS |
17-OH progesterone (ng/dL) | 34.0 +/− 35.6 | 26.4 +/− 24.1 | 35.0 +/− 9.64 | NS |
DHEA-sulfate (ug/dL) | 97.7 +/− 78.7 | 76.0+/− 48.6 | 108 +/− 102 | NS |
Androstenedione (ng/dL) | 18.0 +/− 9.46 | 19.5+/− 8.05 | 20.5 +/−9.19 | NS |